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(From the Basel Institute for Immunology, Grenzacherstrasse 487, Postfach, 4005 Basel 5, 
Switzerland) 
Immune responses which give rise to the synthesis of antibodies of restricted 
heterogeneity can be reproducibly induced in rabbits and mice by streptococcal 
polysaccharide antigens (1, 2). While these reports have demonstrated clonotype 
restriction in the immune serum of rabbits and mice, they give little informa- 
tion with respect to the clonotype restriction in a single reaction site of  organized 
lymphoid tissue,  for example a  single lymph node.  The kinetics of immune 
responses in lymph nodes in situ have been studied in sheep using a variety of 
antigens (3-6), and a substantial body of information is available on the changes 
in cell output, cell type, and the number of antibody-secreting  cells which occur 
within the efferent lymph of antigen-stimulated lymph nodes. However, there is 
no information with respect to the amount and the heterogeneity of antibody 
that is secreted by the lymph node or cells within the efferent lymph. 
In the  present report we have examined the temporal sequence of clonal 
restriction in  the  efferent lymph of individual  sheep popliteal  lymph nodes 
undergoing an immune response to the streptococcal group A-variant polysac- 
charide (Av-CHO). 
Materials and Methods 
Experimental  Protocol.  The  surgical  procedures  used  for  the  cannulation  of afferent  and 
efferent ducts  of popliteal  lymph  nodes  were  those  described  by  Hall  and  Morris  (7).  After a 
postoperation period of 2 days, group A-variant streptococcal vaccine (strain A486 variant of the 
collection of Dr. R. C. Lancefield, The Rockefeller University, New York) containing 2.5 ~g of the 
Av-CHO in 0.1  ml  saline  was  infused  into the lymph  node  via an  afferent lymphatic  vessel. 
Efferent lymph was collected 8 h  before infusion of antigen and  thereafter at 6-18-h intervals 
throughout the entire experiment. 
Cell Output  and Plaque-Forming  Cell (PFC) Response.  The  number  of cells in  any  given 
lymph  sample  was  determined  using  a  calibrated  Model  FN Coulter counter  with  a  100  ~m 
aperture.  The cell count is expressed as cell output per hour (Fig.  1). 
Sheep red blood cells were coated with the O-stearoyl ester of the isolated, chemically pure Av- 
CHO,  as  described  by Read  and  Braun  (8).  The  coated  red  cells were  used  to  detect  PFC  in 
Cunningham slide chambers (9). 
Antibody Output.  The amount of Av-CHO-specific antibody secreted into the efferent lymph 
was  measured  by a  modified Farr assay  (10,  11)  which employed  ~25I-labeled Av-CHO (12).  In 
addition,  the  molecular restriction  of IgG antibodies  was determined  by  analytical  isoelectric 
focusing (IEF) in polyacrylamide gels (13) using z31I-labeled Av-CHO for specific binding (12). The 
pelyacrylamide gels were subsequently exposed to photographic films to determine the position of 
Av-CHO-specific antibodies,  as described previously (12). 
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Fro.  1.  The output of lymphoid cells, Av-CHO-specific PFC, and anti-Av-CHO antibody 
from a  cannulated sheep popliteal lymph node (Sheep 182) after infusion into the afferent 
lymphatic vessel of A486 variant streptococcal vaccine containing 2.5 ~g of Av-CHO. 
Results and Discussion 
Popliteal lymph nodes of three sheep were cannulated,  and they were stimu- 
lated by a  streptococcal group A-variant  vaccine.  In the following, a  detailed 
description of one such typical experiment obtained with one sheep is given; the 
data are summarized in Figs.  1 and 2.  Stimulation  with this bacterial vaccine 
led  to  changes  in  cell  output  similar  to  those  observed with  other  antigens 
employed in this experimental  model (4-7).  PFC specific for the Av-CHO first 
appeared 60 h  after the infusion of antigen  and reached a  peak output in the 
efferent lymph some 20 h later; it coincided with the peak of total cell output in 
the efferent lymph. Around 180 h  after the infusion of antigen a  second minor 
peak of Av-CHO-specific PFC was observed in the efferent lymph. From 60 to 
120 h after antigen was given, 25 x  106 PFC were collected in efferent lymph and 
9 ×  106 were collected from 120 to 264 h. After 264 h the output of PFC was in the 
order of 2,000 PFC per hour. 
Av-CHO-specific antibodies were first detected in the efferent lymph, 60-72 h 
after antigen had been infused. The peak antibody secretion of 800 ~g/h (110-120 
h) was preceded by the peak output of Av-CHO-specific PFC (80 h). The level of 
Av-CHO-specific antibody in the  efferent lymph then  gradually decreased to 
300-400 ~g/h and at the conclusion of the experiment (336 h) had fallen to 200 
#g/h (Fig. 1). During the experimental period of 336 h the popliteal lymph node 
of sheep No. 182 had secreted a total of 83 mg Av-CHO-specific antibody into the 
efferent lymph. Inasmuch as the peak secretion of antibody was preceded by the 
first peak of PFC a large proportion of the antibody must have been synthesized 
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Fro.  2.  IEF of cell-free lymph (30  #1) at various times after the intranodal infusion of A 
486 variant streptococcal vaccine. Exposure to Agfa X-ray film revealed the areas to which 
13'I-labeled Av-CHO has bound to specific antibody. 
Further analysis of the Av-CHO-specific antibody appearing in the efferent 
lymph after infusion of the group A-variant vaccine considered the  class  of 
immunoglobulins secreted and the  degree of heterogeneity at  the clonotype 
level. Analysis of the lymph by radioimmunoelectrophoresis and ultracentrifu- 
gation revealed an early simultaneous secretion of specific IgM and IgG anti- 
body during the peak output of Av-CHO-specific PFC. This IgG fraction occur- 
ring between 60-78 h postinfusion of vaccine consisted of polyclonal Av-CHO 
binding antibody (Fig.  2); it was subsequently replaced (at 83-96 h) by highly 
restricted Av-CHO-specific IgG antibody containing one predominant clonotype 
(pH 6.2-6.5)  among two or three additional clonotypes. It was this restricted 
antibody pattern which persisted for the  rest of the  experimental period in 
roughly equal proportions of the clonotypes to one another. 
The following conclusions can be drawn from the results of the experiments 
reported here: 
(a)  The specific Av-CHO PFC output in efferent lymph after stimulation of 
single lymph nodes with streptococcal A-variant vaccine follows a biphasic pat- 
tern with a major peak of activity occurring at around 80 h and a minor peak at 
around 180 h  after the infusion of antigen. Such a  pattern is similar to that 
induced by lipopolysaccharides in mouse spleen cells (14) and induced by aggre- 
gated heterologous IgG in rabbit spleen cells (15). 710  FROST  ET  AL.  BRIEF  DEFINITIVE  REPORT 
(b)  Specific antibody first appears in the efferent lymph at 60-72 h  after the 
infusion of antigen into the lymph node. PFC occur at around the same time, 
although the peak output of specific antibody (800 ~g/h) does not coincide with 
the peak output of PFC. A single lymph node may secrete as much as 83 mg of 
specific antibody within 336 h  after stimulation with 2.5  ~g of Av-CHO pre- 
sented on whole heat-killed bacteria. 
(c)  After stimulation the initial  secretion of antibodies into the  lymph in- 
volves low levels of heterogeneous IgG antibodies and IgM  antibodies and  is 
followed by clonally restricted IgG antibodies which  dominate the  response. 
Further  work  will  deal  with  this  mode  of selection,  a  selection  that  is  in 
accordance with observations in rabbit and mouse models (16, 17), but opposite 
to that which has been reported for anti-DNP responses (18). 
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